HDAC-IN-50
HDAC-IN-50 is a potent and orally active FGFR and HDAC dual inhibitor with IC50 values of 0.18, 1.2, 0.46, 1.4, 1.3, 1.6, 2.6, 13 nM for FGFR1, FGFR2, FGFR3, FGFR4, HDAC1, HDAC2, HDAC6, HDAC8, respectively. HDAC-IN-50 induces Apoptosis and cell cycle arrest at G0/G1 phase. HDAC-IN-50 decreases the expression of pFGFR1, pERK, pSTAT3. HDAC-IN-50 shows anti-tumor activity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2653339-26-3
- 分子式: C31H41N7O4
- 分子量:575.70
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
FGFR1 0.18 nM (IC50) |
FGFR2 1.2 nM (IC50) |
FGFR3 0.46 nM (IC50) |
FGFR4 1.4 nM (IC50) |
HDAC1 1.3 nM (IC50) |
HDAC2 1.6 nM (IC50) |
HDAC6 2.6 nM (IC50) |
HDAC8 13 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
0.04 μM
Compound: 10e
|
Antiproliferative activity against human A2780 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human A2780 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| HCT-116 | IC50 |
0.82 μM
Compound: 10e
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| Jurkat | IC50 |
15.14 μM
Compound: 10e
|
Antiproliferative activity against human Jurkat cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human Jurkat cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| K562 | IC50 |
2.46 μM
Compound: 10e
|
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human K562 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| KATO III stomach cancer cell line | IC50 |
0.0008 μM
Compound: 10e
|
Antiproliferative activity against human KATO III stomach cancer cell line assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human KATO III stomach cancer cell line assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| KATO III stomach cancer cell line | IC50 |
0.8 nM
Compound: 10e
|
Antiproliferative activity against human KATO III stomach cancer cell line assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human KATO III stomach cancer cell line assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| SNU-16 | IC50 |
0.0007 μM
Compound: 10e
|
Antiproliferative activity against human SNU-16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human SNU-16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
| SNU-16 | IC50 |
0.7 nM
Compound: 10e
|
Antiproliferative activity against human SNU-16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Antiproliferative activity against human SNU-16 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 36449947] |
HDAC-IN-50 (compound 10e) (0.1, 1, 10, 100 nM; 12-84 h) induces apoptosis and cell cycle arrest at G0/G1 phase in a time and dose-dependent manner[1].
HDAC-IN-50 (0, 1.25, 2.5, 5 µM for HCT116 cells, 0, 1, 10, 100 nM for SNU-16 cells; 36 h) decreases the expression of pFGFR1, pERK, pSTAT3 in a dose-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116, SNU-16, KATO III, A2780, K562, Jurkat cells
-
Concentration:0-30 µM
-
Incubation Time:72 h
-
Result:Showed antiproliferative activities with IC50s of 0.82, 0.0007, 0.0008, 0.04, 2.46, 15.14 µM for HCT116, SNU-16, KATO III, A2780, K562, Jurkat cells, respectively.
-
Cell Line:SNU-16 cells
-
Concentration:0.1, 1, 10, 100 nM
-
Incubation Time:12, 24, 36 h
-
Result:Induced cell cycle arrest at G0/G1 phase in a time and dose-dependent manner.
-
Cell Line:SNU-16 cells
-
Concentration:0.1, 1, 10, 100 nM
-
Incubation Time:36, 48, 60, 72, 84 h
-
Result:Induced apoptosis with the apoptotic rate increased 30.8% and 49.6% at 10, 100 nM, respectively.
-
Cell Line:HCT116, SNU-16 cells
-
Concentration:0, 1.25, 2.5, 5 µM for HCT116 cells, 0, 1, 10, 100 nM for SNU-16 cells
-
Incubation Time:36 h
-
Result:Reduced the expression of pFGFR1, pERK, pSTAT3 in a dose-dependent manner.
Pharmacokinetic Parameters of HDAC-IN-50 in female Sprague–Dawley (SD) rats[1].
| dose (mg/kg) | administration route | T1/2 (h) | Tmax (h) | Cmax (ng/mL) | AUC0-∞ (h·ng/mL) | CL (mL/min/kg) | Vss (mL/kg) | F % |
| 2 | IV | 0.98± 0.12 | 0.08 | 1116.63 ± 320.45 | 424.88 ± 89.56 | 80.64 ± 15.59 | 2788.87 ± 765.11 | |
| 5 | IP | 1.83 ± 0.06 | 2 | 101.57 ± 23.05 | 491.25 ± 84.18 | 43.83 | ||
| 30 | PO | 0.77 ± 0.04 | 4 | 442.53 ± 46.33 | 1557.12 ± 355.61 | 24.83 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice (HCT116 xenograft model)[1]
-
Dosage:15, 30 mg/kg
-
Administration:P.o.; daily for 18 days
-
Result:Inhibited the tumor growth and downregulated the expression of pSTAT3, pFGFR1, increased the expression of Ac-H3.
化学情報
-
CAS 番号 2653339-26-3
-
分子量 575.70
-
分子式 C31H41N7O4
-
SMILES
O=C(CCCCCCN1N=CC(C2=NC3=C(N=C2)C=CC(N(CCNC(C)C)C4=CC(OC)=CC(OC)=C4)=C3)=C1)NO
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)